Literature DB >> 23507417

Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.

Sun Ju Chung1, Sebastian M Armasu, Kari J Anderson, Joanna M Biernacka, Timothy G Lesnick, David N Rider, Julie M Cunningham, J Eric Ahlskog, Roberta Frigerio, Demetrius M Maraganore.   

Abstract

BACKGROUND: Prior studies causally linked mutations in SNCA, MAPT, and LRRK2 genes with familial Parkinsonism. Genome-wide association studies have demonstrated association of single nucleotide polymorphisms (SNPs) in those three genes with sporadic Parkinson's disease (PD) susceptibility worldwide. Here we investigated the interactions between SNPs in those three susceptibility genes and environmental exposures (pesticides application, tobacco smoking, coffee drinking, and alcohol drinking) also associated with PD susceptibility.
METHODS: Pairwise interactions between environmental exposures and 18 variants (16 SNPs and two variable number tandem repeats, or "VNTRs") in SNCA, MAPT and LRRK2, were investigated using data from 1098 PD cases from the upper Midwest, USA and 1098 matched controls. Environmental exposures were assessed using a validated telephone interview script.
RESULTS: Five pairwise interactions had uncorrected P-values < 0.05. These included pairings of pesticides × SNCA rs3775423 or MAPT rs4792891, coffee drinking × MAPT H1/H2 haplotype or MAPT rs16940806, and alcohol drinking × MAPT rs2435211. None of these interactions remained significant after Bonferroni correction. Secondary analyses in strata defined by type of control (sibling or unrelated), sex, or age at onset of the case also did not identify significant interactions after Bonferroni correction.
CONCLUSIONS: This study documented limited pairwise interactions between established genetic and environmental risk factors for PD; however, the associations were not significant after correction for multiple testing.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507417      PMCID: PMC4685949          DOI: 10.1016/j.parkreldis.2013.02.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  32 in total

1.  LRRK2 mutations in Parkinson disease.

Authors:  M Farrer; J Stone; I F Mata; S Lincoln; J Kachergus; M Hulihan; K J Strain; D M Maraganore
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

2.  Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.

Authors:  Erin H Norris; Kunihiro Uryu; Susan Leight; Benoit I Giasson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Education and occupations preceding Parkinson disease: a population-based case-control study.

Authors:  R Frigerio; A Elbaz; K R Sanft; B J Peterson; J H Bower; J E Ahlskog; B R Grossardt; M de Andrade; D M Maraganore; W A Rocca
Journal:  Neurology       Date:  2005-11-22       Impact factor: 9.910

4.  Chemical exposures and Parkinson's disease: a population-based case-control study.

Authors:  Roberta Frigerio; Kevin R Sanft; Brandon R Grossardt; Brett J Peterson; Alexis Elbaz; James H Bower; J Eric Ahlskog; Mariza de Andrade; Demetrius M Maraganore; Walter A Rocca
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

5.  Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.

Authors:  Ikuko Mizuta; Wataru Satake; Yuko Nakabayashi; Chiyomi Ito; Satoko Suzuki; Yoshio Momose; Yoshitaka Nagai; Akira Oka; Hidetoshi Inoko; Jiro Fukae; Yuko Saito; Motoji Sawabe; Shigeo Murayama; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Tatsushi Toda
Journal:  Hum Mol Genet       Date:  2006-02-24       Impact factor: 6.150

6.  Phenotypic heterogeneity within a new family with the MAPT p301s mutation.

Authors:  Minoru Yasuda; Yoshitsugu Nakamura; Toshio Kawamata; Hiroshi Kaneyuki; Kiyoshi Maeda; Osamu Komure
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

7.  Multiple regions of alpha-synuclein are associated with Parkinson's disease.

Authors:  Jakob C Mueller; Julia Fuchs; Anne Hofer; Alexander Zimprich; Peter Lichtner; Thomas Illig; Daniela Berg; Ullrich Wüllner; Thomas Meitinger; Thomas Gasser
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

8.  Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

Authors:  Alexander Zimprich; Saskia Biskup; Petra Leitner; Peter Lichtner; Matthew Farrer; Sarah Lincoln; Jennifer Kachergus; Mary Hulihan; Ryan J Uitti; Donald B Calne; A Jon Stoessl; Ronald F Pfeiffer; Nadja Patenge; Iria Carballo Carbajal; Peter Vieregge; Friedrich Asmus; Bertram Müller-Myhsok; Dennis W Dickson; Thomas Meitinger; Tim M Strom; Zbigniew K Wszolek; Thomas Gasser
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

9.  Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

Authors:  An Goris; Caroline H Williams-Gray; Graeme R Clark; Thomas Foltynie; Simon J G Lewis; Joanne Brown; Maria Ban; Maria G Spillantini; Alastair Compston; David J Burn; Patrick F Chinnery; Roger A Barker; Stephen J Sawcer
Journal:  Ann Neurol       Date:  2007-08       Impact factor: 10.422

10.  Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

Authors:  Coro Paisán-Ruíz; Shushant Jain; E Whitney Evans; William P Gilks; Javier Simón; Marcel van der Brug; Adolfo López de Munain; Silvia Aparicio; Angel Martínez Gil; Naheed Khan; Janel Johnson; Javier Ruiz Martinez; David Nicholl; Itxaso Martí Carrera; Amets Saénz Pena; Rohan de Silva; Andrew Lees; José Félix Martí-Massó; Jordi Pérez-Tur; Nick W Wood; Andrew B Singleton
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

View more
  12 in total

1.  Reduced risk of Parkinson's disease associated with lower body mass index and heavy leisure-time physical activity.

Authors:  Katri Sääksjärvi; Paul Knekt; Satu Männistö; Jukka Lyytinen; Tuija Jääskeläinen; Noora Kanerva; Markku Heliövaara
Journal:  Eur J Epidemiol       Date:  2014-03-16       Impact factor: 8.082

Review 2.  Genetics of synucleins in neurodegenerative diseases.

Authors:  José Brás; Elizabeth Gibbons; Rita Guerreiro
Journal:  Acta Neuropathol       Date:  2020-08-01       Impact factor: 17.088

3.  An updated analysis with 45,078 subjects confirms the association between SNCA rs11931074 and Parkinson's disease.

Authors:  Xu Liu; Ruixia Zhu; Tongling Xiao; Qu Li; Ying Zhu; Zhiyi He
Journal:  Neurol Sci       Date:  2018-08-17       Impact factor: 3.307

Review 4.  Disease-Toxicant Interactions in Parkinson's Disease Neuropathology.

Authors:  Gunnar F Kwakye; Rachael A McMinimy; Michael Aschner
Journal:  Neurochem Res       Date:  2016-09-09       Impact factor: 3.996

5.  The Potential Mutation of GAK Gene in the Typical Sporadic Parkinson's Disease from the Han Population of Chinese Mainland.

Authors:  Jie Zhang; Hanyi Zeng; Lei Zhu; Libing Deng; Xin Fang; Xia Deng; Huiting Liang; Chunyan Tang; Xuebing Cao; Yi Lu; Jiao Li; Xiao Ren; Wenjie Zuo; Xiong Zhang; Renshi Xu
Journal:  Mol Neurobiol       Date:  2015-12-17       Impact factor: 5.590

6.  From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.

Authors:  Sara Redenšek; Vita Dolžan; Tanja Kunej
Journal:  OMICS       Date:  2018-01

Review 7.  Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review.

Authors:  Clarissa Loureiro das Chagas Campêlo; Regina Helena Silva
Journal:  Parkinsons Dis       Date:  2017-07-11

8.  RNA-sequencing of peripheral blood circular RNAs in Parkinson disease.

Authors:  Fancong Kong; Zhanyun Lv; Lifang Wang; Kui Zhang; Ying Cai; Qingqing Ding; Zuzhen Sun; Hefu Zhen; Fengjuan Jiao; Qianqian Ma; Chao Nie; Yan Yang
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

Review 9.  Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation.

Authors:  Yufei Liu; Long Niu; Xinyao Liu; Cheng Cheng; Weidong Le
Journal:  Neurosci Bull       Date:  2021-06-15       Impact factor: 5.271

10.  Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.

Authors:  Chen Shi; Zheng Zheng; Qi Wang; Chaodong Wang; Dabao Zhang; Min Zhang; Piu Chan; Xiaomin Wang
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.